Home » Polio Vaccine Licensed for Use in Novel Approach to Global Eradication Efforts
Polio Vaccine Licensed for Use in Novel Approach to Global Eradication Efforts
Sanofi pasteur, the vaccines business of the sanofi-aventis group, has received a license from the Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSAPS) for a new polio vaccine, which is the first new vaccine developed to fight that disease in decades. The new vaccine -- Monovalent Oral Polio Vaccine 1 or MOPV1 -- will be used first in Egypt as a critical part of a new World Health Organization's strategy to end polio transmission by the end of this year.
Yahoo News (http://biz.yahoo.com/prnews/050331/nyth019.html?.v=3)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May